Scholars Central

Conference abstractPublished 27 Sep 2018

From case-series to a placebo-controlled n-of-1 ‘clinical trial’ of topical analgesics in the treatment of peripheral neuropathic pain. How to enhance the level of evidence of a case-report?

Authors: David Kopsky

Institute for Neuropathic Pain | Netherlands

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Case reports have been identifi ed as relevant and important elements in advancing medical scientifi c knowledge. At our Institute for Neuropathic Pain, we treat patients suff ering from symmetrical peripheral neuropathic pain, oft en resistant to most therapies. Since 2010, we have developed a number of compounded topical formulations containing classical co-analgesics such as ketamine, baclofen and phenytoin in treatment-resistant patients and reported the results in case-reports and case-series. We were able to optimize dose and formulations based on the feedback given by the patients. Most of our patients reported a quick analgesic effect, within 20-30 minutes after applying analgesic creams. Case-reports or case series are seen as the lowest level of evidence; therefore, we adapted our approach to the n-of-1 ‘clinical trial’, seen as the ultimate strategy for individualizing medicine. This is possible for symmetrical neuropathic pain states, as a patient can compare the analgesic response on treatments (or placebo) between both feet. We developed first a single-blind placebo-controlled responder test, and currently are designing a double-blind placebocontrolled response test. These tests helped us to better identify responders and exclude placebo responders. Using a placebo in a practical setting however is not done frequently, and the ethical justifications of using such placebo will be presented, as well as the results of single-blind and double-blind response test evaluating the safety and efficacy of phenytoin cream in peripheral neuropathic pain. The above serves to underline the importance of case-reports in the emergence of new insights in medicine.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectAnaesthesia & Pain
  • SubjectNeuroscience & Neurology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “David Kopsky”